Celiac disease, a chronic autoimmune disorder triggered by the ingestion of gluten in genetically predisposed individuals, has long been managed solely through a strict gluten-free diet. However, the market landscape is evolving with significant advancements in the Celiac Disease pipeline, aiming to provide pharmaceutical solutions to ease the burden of managing Celiac Disease. The race...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian